BCIIX | RERCX | BCIIX / RERCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 26 years | 23 years | - |
Gain YTD | 7.508 | 6.614 | 114% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 250 | 2,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 83.3M | 131B | 0% |
Annual Yield % from dividends | 0.00 | 1.29 | - |
Returns for 1 year | 4.80 | 1.19 | 405% |
Returns for 3 years | 15.56 | 0.97 | 1,606% |
Returns for 5 years | 18.36 | 6.74 | 272% |
Returns for 10 years | 51.08 | 18.89 | 270% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CVMIX | 18.34 | 0.01 | +0.05% |
Calvert Emerging Markets Equity I | |||
FBIOX | 20.11 | -0.06 | -0.30% |
Fidelity Select Biotechnology | |||
AEDRX | 33.68 | -0.12 | -0.36% |
Invesco EQV European Equity R | |||
VFFSX | 294.71 | -5.11 | -1.70% |
Vanguard 500 Index Institutional Select | |||
SSMGX | 63.06 | -2.33 | -3.56% |
Sit Small Cap Growth |